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sensitivity to negative feedback during risky decision-mak-
ing and higher symptoms of depression and anxiety.
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Introduction
Impulse control disorders (ICDs) are repeated and exces-
sive hedonistic behaviours that interfere in major areas of 
life functioning (Evans et al. 2009). ICDs include the four 
major impulse control disorders (ICDs), namely, pathologi-
cal gambling, hypersexuality, compulsive shopping, and 
binge eating. Other compulsive behaviours such as punding, 
hobbyism, walkabout, hoarding, and dopamine dysregula-
tion syndrome are often reported (Weintraub et al. 2015). 
An estimated 13–35% of PD patients are reported to develop 
clinically relevant ICD (Callesen et al. 2014; Garcia-Ruiz 
et al. 2014; Joutsa et al. 2012; Weintraub et al. 2010). How-
ever, this is likely to be an underestimation of their real 
prevalence in PD, for a number of reasons. First, people 
experiencing ICDs are reluctant to report them to their cli-
nician due to embarrassment and shame. Second, patient’s 
insight may lack, even when caregivers recognize ICD as 
problematic, and information from caregivers is lacking in 
some studies in PD. Third, diagnostic criteria for gambling, 
binge eating (American Psychiatric Association 2013), and 
compulsive shopping (McElroy et al. 1994) do not consider 
ICDs as a continuum of severity and score them as either 
present or absent. Therefore, risky behaviours that fall short 
of the threshold will not receive a diagnosis even when they 
may impact on quality of life, health behaviours, financial 
stability, and relationships of patients and their families. 
Abstract Impulse control disorders (ICDs) in Parkinson’s 
disease (PD) are considered dopaminergic treatment side 
effects. Cognitive and affective factors may increase the risk 
of ICD in PD. The aim is to investigate risky decision-mak-
ing and associated cognitive processes in PD patients with 
ICDs within a four-stage conceptual framework. Relation-
ship between ICDs and affective factors was explored. Thir-
teen PD patients with ICD (ICD+), 12 PD patients without 
ICD (ICD−), and 17 healthy controls were recruited. Over-
all risky decision-making and negative feedback effect were 
examined with the Balloon Analogue Risk Task (BART). 
A cognitive battery dissected decision-making processes 
according to the four-stage conceptual framework. Affective 
and motivational factors were measured. ANOVA showed no 
effect of group on overall risky decision-making. However, 
there was a group × feedback interaction [F (2, 39) = 3.31, 
p = 0.047]. ICD+, unlike ICD− and healthy controls, failed 
to reduce risky behaviour following negative feedback. A 
main effect of group was found for anxiety and depression 
[F(2, 38) = 8.31, p = 0.001], with higher symptoms in ICD+ 
vs. healthy controls. Groups did not differ in cognitive out-
comes or affective and motivational metrics. ICD+ may 
show relatively preserved cognitive function, but reduced 
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They are important issues, as unrecognized and/or untreated 
ICDs will increase both the direct and indirect costs of PD.
A widely held view suggests that ICDs are side effects 
of dopaminergic replacement therapy (DRT) prescribed to 
ameliorate the cardinal motor symptoms of PD (Voon et al. 
2007, 2011a). According to the “overdose hypothesis”, the 
requisite dopaminergic state necessary to control motor 
symptoms has the potential to move the same patient away 
from their optimum for certain cognitive functions (Cools 
et al. 2001; Cools and Robbins 2004; Gotham et al. 1988; 
Rowe et al. 2008), including decision-making. According 
to this hypothesis, the relationship between the efficiency of 
neuronal activity and the state of dopaminergic modulation 
is represented by a Yerkes–Dodson inverted U-shaped curve 
with decision-making and cognitive function declining with 
deviation away from optimum dosage for motor symptoms, 
indicated by the centre of the curve. This model implies that 
DRT may both improve and impair risk-taking behaviour 
depending on baseline dopamine levels in the underlying 
mesolimbocortical circuitry.
In the largest cross-sectional study of ICD in PD reported 
to date, at least one ICD was present in 13.6% of the cohort, 
ICDs were more common in patients medicated with both 
a dopamine agonist (DA) and levodopa (l-Dopa) com-
pared to those taking only a DA or l-Dopa and a number 
of other factors, including younger age, being unmarried, 
current smoking, and a family history of gambling prob-
lems independently increased the risk of ICD (Weintraub 
et al. 2010). This study, also supported by wider literature 
findings, suggests a more complex relationship that includes 
both DRT and non-DRT factors. Converging evidence sug-
gests that psychological factors, including depression, anxi-
ety, and apathy, may contribute to ICD in PD (Callesen et al. 
2014; Joutsa et al. 2012; Leroi et al. 2012; O’Sullivan et al. 
2011; Pineau et al. 2016; Pontieri et al. 2015; Pontone et al. 
2006; Voon et al. 2011b; Wu et al. 2015). In addition, a 
recent meta-analysis found impairment of decision-making, 
abstraction ability/concept formation, set-shifting, and visu-
ospatial/constructional abilities as cognitive risk factors for 
ICD (Santangelo et al. 2017).
According to Sinha et al.’s (2013) conceptual framework, 
decision-making comprises four dissociable stages: option 
generation, option selection, action initiation or inhibi-
tion, and learning. The generation of behavioural options 
relies, at least in part, on perceptual and attentional mecha-
nisms. These options are then valued and compared based 
on features including predicted reward, punishment, effort 
required, time involved to outcome delivery, and probabil-
ity of outcome. The selected option is then associated with 
the appropriate action, but there is a fail-safe mechanism, 
whereby such action can be inhibited if the wider con-
text changes and the chosen option is no longer advanta-
geous. The real outcomes of behaviours are compared with 
predicted ones. Such comparisons play a key role in learning 
and feeding back on option selection mechanisms. Cognitive 
processes underlying each of these stages may be modu-
lated, to some extent, by dopamine, with either lower or 
higher dopamine levels leading toward apathy or impulsiv-
ity according to the previously described inverted U-shaped 
curve. Moreover, factors other than dopaminergic modula-
tion such as depression or anxiety can also influence pro-
cesses within each stage.
Sinha et al. (2013) suggest that abnormal dopaminergic 
modulation of any one or combination of the four stages 
increases ICD vulnerability. Preliminary evidence provides 
partial support for this view. PD patients with ICD show 
disrupted option generation, since they seek less information 
before making a decision (Djamshidian et al. 2012, 2014) 
and abnormal option selection, as demonstrated by increased 
temporal discounting (i.e., the preference for immediate 
smaller rewards than bigger ones in the future) (Housden 
et al. 2010; Voon et al. 2010b). On the other hand, action ini-
tiation and inhibitory control appear to be relatively spared 
in PD patients with ICD based on performance on the Stop 
Signal and the Stroop tasks (Claassen et al. 2015; Djamshid-
ian et al. 2011; Ricciardi et al. 2017). Similarly, learning 
from rewards was reported to be spared in PD with ICD 
(Piray et al. 2014; Voon et al. 2010a), whereas the effect of 
negative feedback on learning appears equivocal, with stud-
ies reporting either impairment (Leplow et al. 2017; Piray 
et al. 2014), sparing (Djamshidian et al. 2010) or no differ-
ence (Claassen et al. 2011).
To offer more information on this still unclear topic, we 
explored risky decision-making in PD with the Balloon Ana-
logue Risk Task (BART), and dissected the four stages of 
the underlying conceptual framework (Sinha et al. 2013) 
through a battery of cognitive tests. The BART is a risk-
taking task-related reward decision-making, where choices 
are based on explicit probabilistic information (Lejuez et al. 
2002). The BART was shown to be an ecologically valid 
and sensitive measure of risk-taking behaviour, positively 
correlating with both self-report impulsivity and real-world 
risky behaviours, such as number of sexual partners, alcohol, 
smoke, and drug use (Hopko et al. 2006; Lejuez et al. 2002, 
2003a, b). In addition, the BART has good reliability prop-
erties. Risk-taking behaviour on the BART does not differ 
across days. In addition, test–retest correlations across ses-
sion are robust (r = + 0.77) (White et al. 2008).
A secondary focus was the relationship between ICD and 
previously identified affective and motivational factors.
In relation with our primary aim, we predicted that the 
cognitive profile of PD patients with ICD would be marked 
by a risky decision-making deficiency on the BART. Fur-
thermore, according to the decision-making’s framework 
(Sinha et  al. 2013) and wider PD literature, ICD risky 
decision-making deficit may be related to impairments in 
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option generation, option selection, and learning. The extent 
to which inhibitory control is involved remains uncertain, 
given that three studies report sparing of PD with ICD per-
formance on the Stop Signal task and Stroop tasks relative to 
PD without ICD performance (Claassen et al. 2015; Djam-
shidian et al. 2011; Ricciardi et al. 2017).
In relation with the secondary aim, we predicted that the 
PD with ICD group would be characterized by increased 
levels of depression, anxiety, and impulsivity but not apathy.
Materials and methods
Participants
PD patients were identified from a secondary care outpa-
tient PD clinic and recruited if they met the following inclu-
sion criteria: (a) idiopathic PD diagnosed by the UK PD 
Society Brain Bank Clinical Diagnostic Criteria (1992); (b) 
mild-to-moderate PD, defined as Hoehn and Yahr (H–Y) 
score 1–3 in ON condition; (c) Mini Mental State Exami-
nation ≥ 25/30; (d) able to provide written informed con-
sent; (e) age = 35–85 years; and (f) medicated with levo-
dopa (l-Dopa), dopamine agonists (DAs; i.e., pramipexole, 
ropinirole, rotigotine, apomorphine), monoamine oxidase 
B (MAO) inhibitors (i.e., selegiline, rasagiline), catechol-
O-methyltransferase (COMT) inhibitors (i.e., tolcapone, 
entacapone), and/or amantadine.
Exclusion criteria were: (a) co-morbidity for other neu-
rological illnesses other than PD; (b) history of learning dif-
ficulty including dyslexia; (c) physical inability to attend 
or comply with treatment scheduling, such as upper limb 
amputation, or crippling degenerative arthritis; (d) active 
malignancy; (e) family history of PD; (f) psychosis; (g) inca-
pacitating dyskinesia on a stable dose of l-Dopa; and (h) 
medicated with either a centrally acting anticholinergic or 
atypical antipsychotic agents.
A total of 13 PD patients were allocated to the ICD 
(ICD+ group) and 12 as not harbouring ICD (ICD− group) 
by a certified neurologist (SJE) using published diagnostic 
criteria for dopamine dysregulation syndrome in PD (Gio-
vannoni et al. 2000), punding (Evans et al. 2004), gambling 
disorder and binge-eating disorder (American Psychiatric 
Association 2013), compulsive shopping (McElroy et al. 
1994), and hypersexuality (Voon et al. 2006). All ICD+ 
patients experience ICD in the 3 months preceding the 
screening visit.
The ICD+ and ICD− groups did not differ in any of 
the following clinical characteristics: age at PD onset, dis-
ease duration, Unified Parkinson’s Disease Rating Scale 
(UPDRS) parts III and IV, H–Y score, DA agonist use, 
and l-Dopa equivalent daily dosage (mg) (Tomlinson et al. 
2010). None of the patients showed clinically relevant motor 
fluctuations (e.g., wearing off, OFF states).
Seventeen healthy controls provided baseline data for the 
cognitive measures. The control group met the same inclu-
sion/exclusion criteria, apart from those related to PD. The 
three groups (i.e., ICD+, ICD−, and controls) were matched 
for age, sex, and years in education and they did not dif-
fer in current levels of cognitive functioning according to 
the Cambridge Cognitive Examination, (CAMCOG) (Roth 
et al. 1986). Premorbid crystallized IQ, measured with the 
Wechsler Test of Adult Reading (WTAR) (Wechsler 2009a), 
was significantly higher in healthy controls, but compara-
ble between the PD groups. Daytime sleepiness, assessed 
with the Epworth Sleepiness Scale (ESS) (Johns 1991), was 
significantly higher in the ICD+ vs. healthy control group. 
Moreover, the three groups did not differ for marital sta-
tus, alcohol, and cigarette consumptions which are previ-
ously identified risk factors for ICDs in PD (Weintraub et al. 
2010). Baseline data are reported in Table 1.
The study was approved by the NRES Committee West 
Midlands and Keele University research ethic committee. 
No study procedure was initiated before written informed 
consent was obtained.
Cognitive assessment
Risky decision‑making
The Balloon Analogue Risk Task (BART) is a computer-
ized task of risk-taking-related decision-making (Lejuez 
et al. 2002). An illustration of the task is provided in Fig. 1.
Participants sat in front of a 17″ PC screen and were 
instructed to use the mouse to incrementally inflate with 
each click a virtual balloon to gain virtual money. Each 
balloon pump earned 5 pence, but if a balloon was over-
inflated and burst, the earnings were lost. To prevent losing 
money, participants had to stop inflating the balloon before 
it burst and click the “Collect $$$” button. The earnings 
were then transferred to a virtual bank, and a “slot machine 
reward sound” provided auditory feedback. The next trial 
commenced when a new balloon appeared following either 
a balloon burst or when earnings were banked. Each partici-
pant was asked to complete 30 trials.
Balloons were pre-programmed to burst at a “break 
point” in the range of 1–128 pumps. The probability that a 
balloon would burst was 1/128 for the first pump. If it did 
not explode, the probability for bursting was 1/127 for the 
second and so on. Therefore, the average break point was 
64 pumps.
Two dependent variables were recorded. The first was 
the average number of pumps, where the balloon earnings 
were successfully cashed. For this outcome, the higher the 
number of pumps, the greater the risk-taking behaviour. 
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The second was the average number of pumps for trials 
immediately preceding and immediately following a bal-
loon burst (Claassen et al. 2011; Simioni et al. 2012). 
For this outcome, sensitivity for negative feedback was 
expressed as a lower number of pumps in trials that imme-
diately followed a balloon burst compared to those that 
immediately preceded it. Participants were in ON condi-
tion when the BART was administered.
Cognitive battery
A cognitive battery was administered over two consecutive 
days, and at the same time of the day on each occasion. 
Each research session lasted 60–90 min. Patients did not 
show clinically relevant motor fluctuations. The researcher 
was blind to ICD status, but not to PD diagnosis.
Table 1  Baseline data, socio-demographic, habits, and clinical characteristics of the study sample
Continuous variables are presented as mean ± standard deviation, median. Median is reported for variables that were not normally distributed
Significant p values (p < 0.05) are given in bold
ICD+ patients with ICD, ICD− patients without ICD history, HC healthy controls, Education years of formal education, ESS Epworth sleepi-
ness scale, WTAR Wechsler Test of Adult Reading, CAMCOG Cambridge Cognitive Examination (total score), Marital status Married/widowed/
divorced/single, Cigarettes number of cigarettes/week, Alcohol units/week, UPDRS‑III unified Parkinson’s disease rating scale part III (motor 
score), UPDRS‑IV unified Parkinson’s disease rating scale part IV (complications of therapy), H&Y Hoehn–Yahr disease severity rating scale, 
LEDD levodopa equivalent daily dosage, DAs dopamine agonist, NA not available, Single ICD hypersexuality/punding/binge eating/compulsive 
shopping
§| Fisher–Freeman–Halton test
§§ Two-tailed Fisher exact test
§ Post-hoc comparison: HC < ICD+; HC = ICD−; ICD+ = ICD−
† Post-hoc comparison: HC > ICD+; HC > ICD−; ICD+= ICD−
a Log10 transformed data
b Hypersexuality: n = 3, binge eating: n = 1, compulsive shopping: n = 1, punding: n = 3
c Hypersexuality + punding + compulsive shopping: n = 2, hypersexuality + punding: n = 1, hypersexuality + compulsive shopping: n = 1 
hypersexuality + binge eating: n = 1
Variables ICD+ (n = 13) ICD− (n = 12) HC (n = 17) F, t, χ2 values p
Age (years) 64.62 ± 7.6, 65 63.42 ± 10.96, 66 68.65 ± 6.76, 68 F(2, 39) = 1.589 0.217
Male, n (%) 11 (84.6%) 10 (83.3%) 10 (58.8%) 0.271§|
Education (years) 13.77 ± 2.92, 13 13.58 ± 3.15, 12 15.23 ± 3.25, 15 F(2, 39) = 1.266 0.293
ESS 13.42 ± 3.65 9.58 ± 4.38 7.53 ± 4.54 F(2, 38) = 6.767 0.003§
WTAR 108.23 ± 9.83 101.92 ± 6.39 116.12 ± 7.15 F(2, 39) = 11.690 0.0001†
CAMCOG 96.77 ± 3.27, 97 94.75 ± 6.61, 95.5 99.29 ± 2.62, 99 F(2, 39) = 3.095a 0.057
Marital status 10/0/1/1 9/0/2/1 10/2/5/0 0.409§|
Cigarettes 6.67 ± 20.15, 0 0 0 F(2, 38) = 1.605 0.214
Alcohol 6.96 ± 2.37, 5.5 10.46 ± 2.92, 6.5 4.76 ± 0.95, 4 F(2, 38) = 2.053 0.142
Family history
 Alcohol abuse 1 1 0
 ICD 0 0 0
 Drug abuse 0 0 0
PD features
 Age at onset 56.38 ± 7.73 57.08 ± 13.42 NA t(23) = 0.158 0.876
 Duration 8 ± 4.06, 8 7.29 ± 7.51, 5.5 NA U(23) = 58.5 0.286
 UPDRS-III 17.31 ± 5.96 20.92 ± 9.03 NA t(23) = 1.188 0.247
 UPDRS-IV 3.69 ± 3.97 3.17 ± 1.99 NA t(23) = − 0.413 0.683
 H&Y 2.5 ± 0.35 2.41 ± 0.70 NA t(23) = − 0.37 0.716
 LEDD (mg) 552.85 ± 353.42, 450 451.42 ± 293.77, 355 NA U(23) = 61.00 0.355
 DAs use, n (%) 10 (76.9%) 7 (58.3%) NA 0.411§§
ICD type
 Single ICD 3/1/1/3b 0 0
 Multiple ICD 5c 0 0
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The battery provided measures of divided attention 
(Test of Attentional Performance, TAP (Zimmermann 
and Fimm 1995), hit rate), and selective attention [Trail 
Making Test A, TMT-A (Reitan 1958), errors], executive 
function (CAMCOG, executive function subtest score), 
immediate and delayed story recall [Wechsler Memory 
Scale Logical memory subtest (Wechsler 2009b)], mem-
ory (CAMCOG, memory subtest score), verbal genera-
tion [The Hayling test—Section 1 (Burgess and Shallice 
1997), scaled score], motor and verbal inhibitory control 
[Go/no-Go (Zimmermann and Fimm 1995), false alarms 
(i.e., reactions to a non-critical stimulus)]; The Hayling 
test—Section 2 [Burgess and Shallice 1997), scaled score], 
set-shifting [Trail Making Test B, TMT-B (Reitan 1958), 
errors], temporal discounting [the Kirby Delayed Dis-
counting Questionnaire (Kirby et al. 1999) scored accord-
ing to Myerson et al. (2014)], and rule detecting via feed-
back processing [the Brixton Test of Spatial Anticipation 
(Burgess and Shallice 1997), scaled score].
According to the four-stage decision-making framework 
(Sinha et al. 2013), the following outcomes provide esti-
mates of (1) option generation: selective and divided atten-
tion, set-shifting, executive function, and verbal genera-
tion; (2) option selection: temporal discounting; (3) action 
initiation and inhibition: motor and verbal inhibitory con-
trol; and (4) learning: immediate and delayed story recall, 
memory, rule detecting via feedback processing, and nega-
tive feedback sensitivity from the BART.
Affective and motivational factors assessment
Participants also completed subjective estimates of impul-
siveness [Barratt Impulsiveness Questionnaire, BIS-11 (Pat-
ton et al. 1995)], anxiety and depression [Hospital Anxiety 
and Depression Scale, HADS (Zigmond and Snaith, 1983)], 
and apathy [Starkstein Apathy Scale (Starkstein et al. 1992)]. 
The questionnaires were completed at home between the two 
research sessions.
Statistical analysis
Data were analysed with SPSS version 21.0 (SPSS, Chicago, 
IL, USA). For continuous variables, normality of distribu-
tion was explored with the Shapiro–Wilks test. For variables 
not normally distributed, log or squared root transformation 
was applied. Normally distributed transformed variables 
were analysed using parametric tests. When transforma-
tion did not solve normality, both parametric and nonpar-
ametric analyses were used to compare groups. Since the 
results were comparable for both types of analysis, results 
of parametric tests were considered, as they assure greater 
statistical power. Bonferroni was used as post-hoc test when 
ANOVA yielded significant differences between the three 
groups. Fisher’s exact test or Fisher–Freeman–Halton test 
was applied to categorical variables. p < 0.05 (two-tailed) 
was set as significance threshold for all the tests, except 
Fig. 1  Balloon Analogue Risk Task (BART). The Balloon Analogue 
Risk Task is provided on a 17″ PC screen. Participants click with the 
mouse on the box labelled “Click Here to Pump up the Balloon” to 
inflate the balloon and earn money. Each pump earns 5 pence. Money 
can be collected by clicking on the box labelled “Collect $$$” and 
then transferred in the virtual bank named “Total $$$”. If the balloon 
is inflated too much, it could burst and the money is lost. Every time, 
a balloon bursts or money is collected, and a new balloon will appear. 
In total, there are 30 balloons. The number of pumps and money 
achieved for the current balloon is displayed in the boxes on the bot-
tom of the screen
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when Bonferroni correction for multiple comparisons was 
applied.
For BART, the average number of pumps on trials, where 
balloons were cashed, was compared between groups with a 
one-way ANOVA. Response to negative feedback was ana-
lysed with a 3 × 2 mixed-model ANOVA with the between-
subjects factor group (ICD+, ICD−, and healthy controls) 
and the within-subject factor condition (pre-, post-burst).
A composite score of memory was calculated (using 
z-scores) from the CAMCOG memory subtest, immediate 
and delayed logical memory. Performance on each of the 
ten cognitive measures was analysed separately with a series 
of one-way ANOVAs, and Bonferroni corrected p < 0.005.
An exploratory Spearman correlational analysis examined 
the relationship between a single discrepancy score, derived 
from the difference in the number of pumps pre- and post-
balloon burst, and the separate measures of selective and 
divided attention, memory, executive function, set-shifting, 
temporal discounting, inhibitory control, and rule detect-
ing via feedback processing. A smaller discrepancy score 
reflects smaller changes in risk-taking behaviour after bal-
loon burst and loss of virtual money.
Results
Risky decision‑making
The three groups did not differ in the average number of 
pumps on trials, where the balloon was cashed [ICD+ 
31.32 ± 11.70; ICD− 34.51 ± 7.17; controls 35.58 ± 13.08; 
F(2, 39) = 0.31, p = 0.73; Table 2, Fig. 2a]. 
A comparison of the number of balloon pumps pre- and 
post-burst revealed no main effect of group [F(2, 39) = 0.23, 
p  =  0.80]. However, there was a main effect of feed-
back [F(1, 39) = 11.23, p = 0.002], indicating that the mean 
number of pumps was significantly lower post- vs. pre-burst 
(pre 35.97 ± 2.11; post 32.48 ± 2.26). The group × feed-
back interaction was also significant [F(2, 39)  =  3.31, 
p = 0.047], reflecting the observation that both the control 
and ICD− groups reduced their average number of pumps’ 
post-burst, whereas the ICD+ group showed no change 
(Fig. 2b). The reduction of pumps’ post-burst was significant 
for the control group [t(16) = 4.30, p < 0.001] and for the 
ICD− group [t(11) = 2.85, p = 0.02], but was not significant 
for the ICD+ group [t(12) = −0.14, p = 0.89].
Cognitive battery
There were no significant differences between the three 
groups for any of the ten cognitive measures considered 
part of the four stages of decision-making using the strict 
Bonferroni corrected p < 0.005 (Table 3).
Affective and motivational factor assessment
HADS total score was significantly different [F(2, 
38) = 8.31, p = 0.001]. Bonferroni’s corrected post-hoc t 
tests revealed higher scores in the ICD+ group (3.68 ± 0.80) 
compared to controls (2.12 ± 1.08, p = 0.001), but no dif-
ference between the ICD+ and ICD− (3.05 ± 1.18) groups 
(p  =  0.43) or between ICD− and controls (p  =  0.068; 
Table 4).
Anxiety subscale score was significantly differ-
ent [F(2, 38) = 3.68, p = 0.035]. ICD+ group showed 
higher scores (8.25 ± 3.74) than controls (4.12 ± 3.31, 
p = 0.032), but there was no difference between ICD+ 
and ICD− (6.42 ± 5.26) groups (p = 0.837) or between 
ICD− and controls (p = 0.432; Table 4). Depression sub-
scale score was significantly different [F(2, 38) = 22.25, 
p = 0.00001]. Controls (1.47 ± 1.01) had lower scores than 
ICD+ (5.92 ± 2.35, p = 0.000002) and ICD− (4.17 ± 2.52, 
p = 0.002), but there was no difference between ICD+ and 
ICD− (p = 0.106; Table 4).
Table 2  Performances in the BART by groups and interactions
Data are presented as mean ± standard deviation
Significant p values (p < 0.05) are given in bold
ICD+ Parkinson’s patients with ICD, ICD− Parkinson’s patients without ICD history, HC healthy controls, SD standard deviation, Average 
adjusted pumps average number of pumps in cashed balloons, PRE number of pumps for trails that immediately precede a balloon burst, POST 
number of pumps for trails that immediately follow a balloon burst
ICD+ (n = 13) ICD− (n = 12) HC (n = 17) F values p
Average 
adjusted 
pumps
31.32 ± 11.70 34.51 ± 7.17 31.58 ± 13.08 F(2, 39) = 0.314 0.733
Negative 
feedback 
sensitiv-
ity
PRE: 32.6 ± 14.12
POST: 32.92 ± 18.01
PRE: 39.36 ± 8.47
POST: 33.23 ± 9.44
PRE: 35.94 ± 15.69
POST: 31.29 ± 14.38
Main effect of feedback F(1, 39) = 11.225 0.002
Main effect of feedback × group F(2, 39) = 3.314 0.002
Main effect of group F(2, 39) = 0.230 0.796
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Scores for apathy and impulsivity from the Starkstein 
Apathy Scale and the BIS-11, respectively, did not differ 
between the three groups (Table 4).
Exploratory correlation analysis
The BART discrepancy score, reflecting the difference in 
the number of pumps pre- and post-burst, negatively cor-
related with the Go/no-Go false alarms [rs(42) = − 0.336, 
p = 0.030]. This finding suggests that the more the sensi-
tivity towards negative feedback, the fewer false alarms 
on the Go/no-Go task. No other correlations between 
BART discrepancy score and the cognitive outcomes 
were significant. Results for the full correlation matrix 
are presented in Table 5.
Discussion
This study investigated cognitive processes associated with 
risky decision-making in PD patients with and without ICD. 
The relationship between ICDs and previously identified 
affective factors was also explored.
In relation with our primary aim, we predicted that the 
cognitive profile of the ICD+ group would be marked by 
a risky decision-making deficit on the BART. The BART 
provides an ecologically valid estimate of risk-taking-
related decision-making, and this is supported by correla-
tions between performance on the BART and self-reported 
impulsivity and risk-taking behaviours in daily life, such as 
drugs abuse, alcohol abuse, and number of sexual partners 
(Hopko et al. 2006; Lejuez et al. 2002, 2003b). Our analy-
ses, however, failed to support this prediction. When the 
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three groups of participants were analysed together, risky 
decision-making performance did not significantly differ 
between ICD+, ICD−, and healthy controls.
These findings, however, can be reconciled with the 
previous reports of BART in PD with ICD (Claassen 
et al. 2011; Rao et al. 2010; Ricciardi et al. 2017). Risky 
decision-making on the BART successfully discriminated 
between ICD+ and ICD− in PD in relation with striatal 
BOLD response, where activation was diminished in ICD+ 
compared to ICD− (Rao et al. 2010), but abnormal brain 
activation in ICD+ was not mirrored by increased behav-
ioural risk-taking. Furthermore, a medication withdrawal 
study showed that DRT increased risk-taking behaviour in 
PD reflecting an interaction between group and medication 
Table 3  Results of the cognitive test battery
Data are presented as mean ± standard deviation, median. Median is reported for variables that were not normally distributed
ICD+ Parkinson’s patients with ICD, ICD− Parkinson’s patients without ICD history, HC healthy controls, TMT‑A errors Trial Making Test Part 
A number of errors, TMT‑B errors Trial Making Test Part B number of errors, Kirby total Kirby Monetary choice questionnaire, CAMCOG EF 
Cambridge Cognitive Examination executive function subtest score
a Log10 transformed data
b Welch test (Levene test statistically significant)
c Two PD patients (one from the ICD+ and one from the ICD− groups) were excluded because not able to complete the TMT-B task
d One patient from the ICD+ group refused to complete the Kirby Questionnaire of Temporal Discounting
Variables ICD+ (n = 13) ICD− (n = 12) HC (n = 17) F values p
(1) Option generation stage
 TMT-A errors 0.31 ± 0.48, 0 0 ± 0, 0 0.18 ± 0.39, 0 F(2, 39) = 2.209 0.123
 Divided attention hit rate 25.08 ± 3.75, 24 26.08 ± 5.82, 27 28.65 ± 2.50, 30 F(2, 39) = 3.056a 0.058
 TMT-Bc errors 1.17 ± 1.53, 0.5 0.64 ± 0.67, 1 0.65 ± 0.93, 0 F(2, 37) = 0.967 0.390
 Hayling Section 1 scaled score 5.46 ± 1.13, 6 4.75 ± 1.81, 6 5.65 ± 0.93, 6 F(2, 39) = 1.206b 0.319
 CAMCOG EF 21.15 ± 2.97 20.83 ± 5.22 24.35 ± 2.37 F(2, 39) = 6.109b 0.008
(2) Option selection stage
 Kirby  totald 0.47 ± 0.14 0.34 ± 0.12 0.49 ± 0.13 F(2, 38) = 4.658 0.016
(3) Action initiation and inhibition stage
 Go/no-Go false alarms 1.15 ± 1.28, 1 1.08 ± 2.27, 0 0.47 ± 0.72, 0 F(2, 39) = 0.988 0.381
 Hayling Section 2 scaled score 5.31 ± 1.11 5.92 ± 0.67 6.06 ± 0.56 F(2, 39) = 3.519 0.039
(4) Learning stage
 Memory composite score 0.03 ± 0.83 − 0.54 ± 1.05 0.35 ± 0.64 F(2, 39) = 4.036 0.026
 Brixton scaled score 3.46 ± 2.37, 2 3.5 ± 2.54, 2 5.65 ± 2.29, 6 F(2, 39) = 4.173 0.023
Table 4  Affective and 
motivational characteristics by 
groups
One participant from the ICD+ group refused to complete the questionnaires. Data are presented as 
mean ± standard deviation, median. Median is reported for variables that were not normally distributed
Significant p values (p < 0.05) are given in bold
ICD+ Parkinson’s patients with ICD, ICD− Parkinson’s patients without ICD history, HC healthy controls, 
SD standard deviation, HADS Hospital Anxiety and Depression scale total score, HADS‑A Hospital Anxi-
ety and Depression scale anxiety sub scale, HADS‑D Hospital Anxiety and Depression scale depression 
sub scale, SAS Starkstein Apathy scale, BIS‑11 Barratt Impulsiveness Scale total score
a Squared root transformed data
b Welch test (Levene test statistically significant)
c Post-hoc comparison: HC < ICD+; HC = ICD−; ICD+ = ICD−
d Post-hoc comparison: HC < ICD+; HC < ICD−; ICD+ = ICD−
ICD+ (n = 12) ICD− (n = 12) HC (n = 17) F values p
HADS 14.17 ± 5.72, 15.5 10.58 ± 7.45, 9.5 5.59 ± 3.97, 5 F(2, 38) = 8.313a 0.001c
HADS-A 8.25 ± 3.74 6.42 ± 5.26 4.12 ± 3.31 F(2, 38) = 3.683 0.035c
HADS-D 5.92 ± 2.35, 6.5 4.17 ± 2.52, 3.5 1.47 ± 1.01, 1 F(2, 38) = 22.25b 0.00001d
SAS 12.25 ± 4.75 11.66 ± 4.03 9.82 ± 2.94 F(2, 38) = 1.593 0.217
BIS-11 60.75 ± 10.28 58.33 ± 9.80 57.35 ± 10.59 F(2, 38) = 0.392 0.679
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state, but there were no differences in risky decision-making 
behaviour between ICD+ vs. ICD− PD patients (Claassen 
et al. 2011).
These previous negative findings were suggested to 
depend on the use of a modified BART version, since a 
reduced range of possible pumps was found to be less sensi-
tive to individual variability in task performance and, there-
fore, diminished the likelihood of detecting differences in 
risk-related constructs and self-report real-world behaviours 
(Lejuez et al. 2002).
The present BART data, which showed that risk-taking-
related decision-making is spared in our cohort of ICD+ 
patients in comparison with ICD− and healthy control 
groups, together with results of the cognitive battery, offer 
an alternative explanation. According to Sinha et al.’s (2013) 
framework, decision-making is dependent on option genera-
tion, selection, action initiation and inhibition, and learning 
stages. Therefore, the likelihood of risky decision-making 
impairment will depend on the nature and extent of impair-
ments within and across these four stages. We showed that 
cognitive processes underlying option generation, selection, 
and action initiation and inhibition in ICD+ were not dif-
ferent from other groups. However, we found an interaction 
between negative feedback and group, suggesting an impair-
ment in the learning stage of decision-making process, that, 
despite being present, it is probably not by itself sufficient 
to affect overall risky decision-making performance on the 
BART. Interestingly, risky behaviour after negative feedback 
on the BART was significantly different in ICD+ patients, 
but performance on the cognitive tasks related to learning 
did not differ across groups. Therefore, learning appeared 
not to be abnormal in PD patients with ICD, unless reward 
is involved. Our findings are in keeping with the notion that 
learning and reward are supported by two separate cortico-
striatal–thalamocortical circuits, i.e., associative and limbic 
circuits, respectively. The associative circuit links the dorso-
lateral prefrontal cortex with the dorsal caudate nucleus, and 
the limbic circuit links the ventral striatum with the ventral 
medial prefrontal cortex, orbitofrontal cortex, dorsal anterior 
cingulate cortex, amygdala, and hippocampus (Vriend et al. 
2014b). We may speculate on a differential dopaminergic 
modulation of these two circuits in PD patients.
Abnormal response to negative feedback deficit was fre-
quently reported in PD (Di Rosa et al. 2015; Frank et al. 
2004; Jocham and Ullsperger, 2009; Volpato et al. 2016). 
Our study may extend this notion, suggesting that this 
impairment is more severe in ICD+ PD patients. According 
to Claassen et al. (2011), we scored negative feedback pro-
cessing by comparing the number of pumps on the trials that 
immediately precede to those on trials immediately follow-
ing a balloon bursts. Sensitivity toward negative feedback 
should result in decrease on risk-taking behaviour after a 
burst. Interestingly, we found reduced sensitivity to negative 
feedback in ICD+, while Claassen et al. (2011) failed to 
report differences between groups. As discussed above, we 
interpret these conflicting findings as due to differences on 
BART tasks used. Lower ranges of possible pumps could 
have decreased the variability across the overall score, 
as well as the trials considered for the negative feedback 
analysis.
According to event-related potential studies, negative 
feedbacks in BART are processed in the anterior cingu-
late cortex (ACC) (Schultz 1998, 2010), and are related to 
the reinforcement learning processes in the brain (Holroyd 
and Coles 2002) and the phasic dopaminergic dip signals. 
The ACC uses this signal to learn which action should be 
selected and executed. This provides a mechanism through 
which actions and events are linked to their outcomes with 
the goal of supporting decisions that maximize the opportu-
nity to encounter reward in the future (Cockburn and Frank 
2011).
Every time an outcome is better than expected or an 
unpredicted reward is received, DA neurons increase their 
phasic firing activity, and a positive prediction error is gen-
erated. In addition, every time an outcome is worse than 
expected or predicted reward is not delivered, there is a pha-
sic dip in the DA neurons firings, and a negative prediction 
error is generated (Schultz 1998, 2010). DRT could prevent 
the DA neurons dip associated with negative feedback, as 
PD patients in OFF state are better when learning from nega-
tive than positive feedback, but they behave in the opposite 
way when ON medication (Frank et al. 2004). In both cases, 
not correctly generated prediction errors might lead toward 
abnormal links between actions and outcomes and impulsive 
behaviours may be facilitated.
In our study, the exploratory correlation analysis revealed 
a positive correlation between the BART discrepancy score 
and the number of false alarms in the Go/no-Go task sup-
porting the importance of negative feedback processing for 
impulse control. The more participants decrease their risky 
behaviour after a negative feedback, and the fewer false 
alarms they make on the motor impulsivity task.
We also predicted that ICD+ would be characterized by 
increased impulsivity, and more symptoms of depression 
and anxiety but not apathy. Conversely, from our predic-
tion, impulsivity levels were comparable between the three 
groups. BIS-11, which has not been validated in PD yet, may 
fail to differentiate between ICD− and ICD+ due to impul-
sivity presenting as a continuum of severity in PD despite 
the absence of clinical ICD. Comparable BIS-11 total score 
between ICD+ and ICD− is in keeping with the previous 
reports (Antonini et al. 2011).
We found depression and anxiety to be significantly 
higher in the ICD+ group than in healthy controls, but 
comparable between PD groups. The lack of differences 
between PD groups on the HADS score precludes any strong 
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statement about the role of depression or anxiety in ICD. 
Nonetheless, the fact that ICD+ and healthy controls signifi-
cantly differ on the HADS score may suggest one of the two 
not mutually exclusive explanations. The first is that higher 
depression and anxiety levels might increase vulnerability 
toward ICD in PD. Depression often precede PD diagnosis 
by several years (Ishihara and Brayne 2006; Tolosa et al. 
2009) and both anxiety and depression symptoms are higher 
in PD than in the general population (Lieberman 2006; Pre-
diger et al. 2012). In a subset of vulnerable PD patients, 
depression and anxiety symptoms could increase the risk 
of develop ICD as coping mechanisms. This hypothesis is 
supported by a retrospective study that showed higher base-
line depression scores on drug naïve-PD patients who later 
developed ICD compared to PD patients who did not (Vriend 
et al. 2014a). Second, depression and anxiety could result as 
consequence of ICDs negative implications in patients and 
caregivers, as supported by reports of reduced quality of life 
in PD patients with ICD (Leroi et al. 2011; Phu et al. 2014).
Limitations
There are several limitations in our study. First, this study 
has a small sample size and consequently low statistical 
power. Any interpretation of the results should be cautiously 
considered, since real differences between groups might 
fail to emerge when the number of participants is small. 
In the literature, underpowered studies investigating cogni-
tion in PD patients with ICD are frequent, as supported by 
a recently published meta-analysis in which 50% (17/34) 
of the studies reported have 20 or less participants in each 
group (Santangelo et al. 2017). Low recruitment rates are 
not surprising when experimental studies involve vulnerable 
older adults affected by a neurological condition such as 
PD which include motor, affective, and cognitive disabili-
ties. Recruitment is even harder when studies focus on ICDs 
that are perceived with a sense of guiltiness, shame, and 
embarrassment. For these reasons, many PD patients with 
ICDs might be reluctant on taking part in research. Nonethe-
less, the small sample size and consequently reduced power 
are likely to affect our negative findings but not the results 
showing reduced sensitivity toward negative feedback in 
ICD+ vs. ICD− and healthy controls, or the higher depres-
sion levels in the ICD+ vs. healthy controls. Moreover, the 
small sample size prevented us to conduct separate analysis 
for ICD and punding, being the latter a probably separated 
but related phenomenon (Evans et al. 2009; Vriend et al. 
2014b). Future and more powered studies are needed to fur-
ther investigate cognitive and affective profiles of different 
types of ICDs.
Second, in the BART, not all the four components of 
the Sinha et al.’s (2013) framework could be measured, but 
only risk-taking behaviour after negative feedback, which we 
interpret as part of the learning stage. The framework’s com-
ponents were assessed with the cognitive battery that was 
not significantly different between groups. The negative find-
ings of the cognitive battery prevent any robust conclusion 
on the component(s) involved in the abnormal behaviour 
in PD patients with ICD. For example, ICD+ patients may 
not modify behaviour following negative feedback because 
of abnormal option selection mechanism, such as increased 
salience of rewarding stimuli. Further studies should include 
a task that can be broken down in the four different compo-
nents of Sinha’s framework.
Third, healthy controls had significant higher scores in 
the WTAR, which is a measure of crystallized intelligence. 
This is unlikely to have affected our results, since partici-
pants showed comparable performances in CAMCOG, an 
extensive cognitive evaluation. Furthermore, since the com-
parable WTAR performances of the two PD groups, it is 
unlikely that ICD+’s abnormal responses to negative feed-
back were linked to crystallized intelligence.
Fourth, daytime sleepiness was significantly higher in 
ICD+ patients than healthy controls. However, it is unlikely 
that sleepiness levels could have affected our study results, 
since we found comparable outcomes in cognitive evalua-
tion. Increased daytime sleepiness has already been reported 
in PD patients with ICD (O’Sullivan et al. 2011; Pontone 
et al. 2006; Scullin et al. 2013), probably because both rep-
resent side effects of DRT, especially DAs.
Fifth, ICD were diagnosed with a semi-structured inter-
view following diagnostic criteria. This point might make 
direct comparison to the previous studies using QUIP-RS, a 
tool specifically validated in PD with ICD, difficult. None-
theless, our more conservative approach assured that only 
patients with clinically relevant ICD were categorized as 
ICD+.
Sixth, UPDRS-III was administered at the screening visit 
only; therefore, the ON medication state was not controlled 
during all the assessment. Nonetheless, PD patients had 
low UPDRS-IV scores and they did not show any disabling 
motor fluctuation and/or OFF states.
Finally, other cognitive processes that have not been 
investigated in this study (e.g., incentive salience) may inde-
pendently increase the risk to develop ICD or interact with 
negative feedback processing facilitating ICD development 
and/or maintenance.
Conclusions
In conclusion, our findings suggest that abnormal negative 
feedback processing is a cognitive feature of ICD in PD 
which could account for impulsive behaviour in situations 
that involve both rewards and punishments. In addition, ICD 
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in PD is associated with increased anxiety and depression 
than general population. Further studies are needed to under-
stand whether abnormal negative feedback processing pre-
cedes ICD development, thereby constituting a premorbid 
vulnerability factor.
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